Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

Durable survival and deep, lasting remissions in checkpoint-refractory, heavily pretreated cancers with median OS of ~23 months with agenT-797 ...

Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment HONG KONG, Nov. 13, 2025 /PRNewswire/ — Hosted by ...

Purdue Pharma L.P. ("Purdue") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pipeline drug tinostamustine for the treatment of ...

Positron emission tomography (PET), when combined with computed tomography (CT), has become one of the most powerful diagnostic tools in cancer medicine.

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...